Relapse-Prevention Study With Levomilnacipran ER (F2695 SR) in Patients With Major Depressive Disorder

NCT01085812 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

734

Enrollment

INDUSTRY

Sponsor class

Conditions

Depression
Major Depressive Disorder

Interventions

DRUG: Levomilnacipran ER
DRUG: Placebo

Sponsor

Forest Laboratories